银屑病对幼年银屑病关节炎患者身心健康及临床结局的影响
研究基于英国多中心幼年特发性关节炎起始队列(2001年1月至2018年3月),比较幼年银屑病关节炎(JPsA)与其他JIA类别患者报告结局,以及JPsA内部伴与不伴银屑病者的差异。结果显示,JPsA与非JPsA诊断时患者报告结局无显著差异;JPsA中伴银屑病者抑郁症状更多(系数=9.8;95%CI:0.5,19.0);JPsA持续高家长总体评估的比值比为其他ILAR类别的2.3倍(95%CI:1.2,4.6)。
要点
- JPsA与非JPsA诊断时患者报告结局无显著差异。
- JPsA中伴银屑病者诊断时抑郁症状多于不伴银屑病者(系数=9.8;95%CI:0.5,19.0)。
- JPsA持续高家长总体评估的比值比为其他ILAR类别的2.3倍(95%CI:1.2,4.6)。
核心结论
- JPsA诊断时伴银屑病的儿童和青年报告情绪更差,提示皮肤与关节同时受累者疾病影响更大。
- 作者认为,对JPsA合并银屑病的儿童加强多学科照护并关注身心健康可能有助于改善这些结局。
研究设计与样本
- 研究纳入2001年1月至2018年3月期间招募至儿童关节炎前瞻性研究(英国多中心JIA起始队列)的儿童和青年。
- 诊断时收集患者/家长报告结局,包括家长总体评估(10 cm视觉模拟量表)、功能能力(儿童健康评估问卷)、疼痛(10 cm视觉模拟量表)、健康相关生活质量(儿童健康问卷PF50心理社会评分)、情绪/抑郁症状(情绪与感受问卷)及家长心理健康(一般健康问卷30)。
- 采用多变量线性回归比较JPsA与其他JIA类别,以及JPsA内部伴与不伴银屑病者的患者报告结局和结局轨迹。
主要发现
- JPsA与非JPsA儿童和青年诊断时患者报告结局无显著差异。
- JPsA中伴银屑病者诊断时抑郁症状多于不伴银屑病者(系数=9.8;95%CI:0.5,19.0)。
- JPsA持续高家长总体评估的比值比为其他ILAR类别的2.3倍(95%CI:1.2,4.6),尽管关节计数和医生总体评估改善。
关键数值与推荐
- JPsA中伴银屑病者与不伴银屑病者抑郁症状比较:系数=9.8;95%CI:0.5,19.0。
- JPsA与其他ILAR类别持续高家长总体评估比较:比值比=2.3;95%CI:1.2,4.6。
临床怎么用
- 作者认为,对JPsA合并银屑病的儿童加强多学科照护并关注身心健康可能有助于改善结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Juvenile PsA (JPsA) has varied clinical features that are distinctive from other JIA categories. This study investigates whether such features impact patient-reported and clinical outcomes. METHODS: Children and young people (CYP) were selected if recruited to the Childhood Arthritis Prospective Study, a UK multicentre JIA inception cohort, between January 2001 and March 2018. At diagnosis, patient/parent-reported outcomes (as age-appropriate) included the parental global assessment (10 cm visual analogue scale), functional ability (Childhood Health Assessment Questionnaire (CHAQ)), pain (10 cm visual analogue scale), health-related quality of life (Child Health Questionnaire PF50 psychosocial score), mood/depressive symptoms (Moods and Feelings Questionnaire) and parent psychosocial health (General Health Questionnaire 30). Three-year outcome trajectories have previously been defined using active joint counts, physician and parent global assessments (PGA and PaGA, respectively). Patient-reported outcomes and outcome trajectories were compared in (i) CYP with JPsA vs other JIA categories and (ii) CYP within JPsA, with and without psoriasis via multivariable linear regression. RESULTS: There were no significant differences in patient-reported outcomes at diagnosis between CYP with JPsA and non-JPsA. Within JPsA, those with psoriasis had more depressive symptoms (coefficient = 9.8; 95% CI: 0.5, 19.0) than those without psoriasis at diagnosis. CYP with JPsA had 2.3 times the odds of persistent high PaGA than other ILAR categories, despite improving joint counts and PGA (95% CI: 1.2, 4.6). CONCLUSION: CYP with psoriasis at JPsA diagnosis report worse mood, supporting a greater disease impact in those with both skin and joint involvement. Multidisciplinary care with added focus to support wellbeing in children with JPsA plus psoriasis may help improve these outcomes.
引用
- Low JM, Hyrich KL, Ciurtin C, et al. The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis. Rheumatology (Oxford). 2024. PMID: 37467079. doi:10.1093/rheumatology/kead370
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。